AMRX Logo

Amneal Pharmaceuticals, Inc. (AMRX) 

NYSE$8.73
Market Cap
$4.03B
Sector
Healthcare
Industry
Drug Manufacturers—Specialty & Generic
Rank in Sector
450 of 924
Rank in Industry
22 of 56

AMRX Insider Trading Activity

AMRX Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$000
Sells
$49,750,59120100

Related Transactions

Kiely Johndirector0$01$142,946$-142,946
Autor Deborah M.director0$04$590,180$-590,180
Alva Emily Petersondirector0$01$712,000$-712,000
Shah NikitaExecutive Vice President0$01$775,000$-775,000
Konidaris TasosExecutive Vice President & CFO0$01$891,000$-891,000
Daly Jason B.SVP, Chief Legal Officer0$04$1.28M$-1.28M
BOYER ANDREW SExecutive Vice President0$03$1.6M$-1.6M
Patel Gautamdirector0$04$2M$-2M
Patel Tushar Bhikhubhai10 percent owner0$01$41.75M$-41.75M

About Amneal Pharmaceuticals, Inc.

Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products, and transdermals across a range of therapeutic categories. The Specialty segment is involved in â€¦

Insider Activity of Amneal Pharmaceuticals, Inc.

Over the last 12 months, insiders at Amneal Pharmaceuticals, Inc. have bought $0 and sold $49.75M worth of Amneal Pharmaceuticals, Inc. stock.

On average, over the past 5 years, insiders at Amneal Pharmaceuticals, Inc. have bought $802,275 and sold $11.84M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 50,000 shares for transaction amount of $210,500 was made by Patel Gautam (director) on 2021‑12‑17.

List of Insider Buy and Sell Transactions, Amneal Pharmaceuticals, Inc.

2025-03-14SalePatel Tushar Bhikhubhai10 percent owner
5M
1.0326%
$8.35$41.75M-1.49%
2025-03-06SaleDaly Jason B.EVP, Chief Legal Officer
46,936
0.0101%
$8.73$409,751-0.23%
2025-03-05SaleKonidaris TasosExecutive Vice President & CFO
100,000
0.0214%
$8.91$891,000-2.23%
2025-03-05SaleBOYER ANDREW SExecutive Vice President
125,000
0.0267%
$8.89$1.11M-2.23%
2025-03-05SaleAlva Emily Petersondirector
80,000
0.0171%
$8.90$712,000-2.23%
2025-03-05SaleDaly Jason B.EVP, Chief Legal Officer
43,064
0.0092%
$8.88$382,408-2.23%
2025-03-03SalePatel Gautamdirector
80,000
0.0176%
$8.90$712,000+0.23%
2025-02-03SalePatel Gautamdirector
80,000
0.0171%
$8.14$651,200+3.61%
2025-01-08SalePatel Gautamdirector
62,590
0.0135%
$8.01$501,346+5.15%
2025-01-02SalePatel Gautamdirector
17,410
0.0039%
$8.01$139,454+7.09%
2024-11-22SaleKiely Johndirector
17,058
0.0037%
$8.38$142,946-2.03%
2024-11-22SaleAutor Deborah M.director
33,229
0.0072%
$8.34$277,130-2.03%
2024-11-21SaleAutor Deborah M.director
6,771
0.0015%
$8.41$56,944-1.02%
2024-11-21SaleDaly Jason B.SVP, Chief Legal Officer
13,665
0.003%
$8.40$114,786-1.02%
2024-11-15SaleDaly Jason B.SVP, Chief Legal Officer
43,657
0.0136%
$8.61$375,887-2.48%
2024-08-15SaleBOYER ANDREW SExecutive Vice President
40,225
0.0136%
$7.85$315,766+6.83%
2024-08-14SaleBOYER ANDREW SExecutive Vice President
22,486
0.0076%
$7.81$175,616+8.19%
2024-08-14SaleShah NikitaExecutive Vice President
100,000
0.0335%
$7.75$775,000+8.19%
2024-05-17SaleAutor Deborah M.director
23,447
0.0076%
$6.73$157,728+20.01%
2024-05-16SaleAutor Deborah M.director
14,553
0.0047%
$6.76$98,378+21.19%
Total: 60
*Gray background shows transactions not older than one year

Insider Historical Profitability

3.46%
Patel Gautamdirector
1808886
0.3915%
$15.79M34+0.6%
BOYER ANDREW SExecutive Vice President
290106
0.0628%
$2.53M24<0.0001%
Kiely Johndirector
267175
0.0578%
$2.33M11+5.19%
Patel ChintuCo-CEO
512566
0.1109%
$4.47M60+5.05%
Patel Chirag K.President & Co-CEO
512566
0.1109%
$4.47M60+5.05%
*Gray background shows insiders who have made transactions during last year

Historical Insider Profitability vs. Competitors

$910,099,463
123
11.52%
$2.58B
$23,522,750
59
-6.74%
$5.36B
$14,599,168
59
12.79%
$1.41B
$86,177,559
48
44.65%
$13.99B
$97,642,477
41
-10.58%
$856.51M

AMRX Institutional Investors: Active Positions

Increased Positions125+75.3%10M+6.68%
Decreased Positions66-39.76%26M-18.29%
New Positions41New2MNew
Sold Out Positions25Sold Out3MSold Out
Total Postitions225+35.54%126M-11.61%

AMRX Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Vanguard Group Inc$129,867.004.79%14.84M+218,025+1.49%2024-12-31
Blackrock, Inc.$110,145.004.06%12.59M+177,458+1.43%2024-12-31
Tpg Gp A, Llc$107,877.003.98%12.33M00%2024-12-31
Rubric Capital Management Lp$93,816.003.46%10.72M00%2024-12-31
Citadel Advisors Llc$78,583.002.9%8.98M+88,675+1%2024-12-31
Dimensional Fund Advisors Lp$43,677.001.61%4.99M+278,653+5.91%2024-12-31
Geode Capital Management, Llc$33,366.001.23%3.81M+26,536+0.7%2024-12-31
Neuberger Berman Group Llc$32,924.001.21%3.76M-24,918-0.66%2024-12-31
State Street Corp$32,359.001.19%3.7M+183,425+5.22%2024-12-31
Nantahala Capital Management, Llc$32,073.001.18%3.67M+995,586+37.29%2024-12-31

Financial Ratios

Summary
Comparison with Competitors

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.